 | Up a level |
Al-Jameel, Waseem, Gou, Xiaojun, Forootan, Shiva S, Fayi, Majed Saad Al, Rudland, Philip S 
ORCID: 0000-0002-7491-0846, Forootan, Farzad S, Zhang, Jiacheng, Cornford, Philip A ORCID: 0000-0002-7146-9258, Hussain, Syed A and Ke, Youqiang ORCID: 0000-0001-5341-8644
(2020)
Correction: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5.
Oncotarget, 11 (31).
3025-.
Naeem, Abdulghani A, Abdulsamad, Saud A, Zeng, Hao, He, Gang, Jin, Xi, Zhang, Jiacheng, Alenezi, Bandar T, Ma, Hongwen, Rudland, Philip S and Ke, Youqiang ORCID: 0000-0001-5341-8644
(2024)
FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells.
International journal of oncology, 64 (2).
18-.
Zhang, Jiacheng
(2019)
Molecular mechanisms of the apoptosis-promoting activity of FABP5 inhibitors in prostate cancer cells.
PhD thesis, University of Liverpool.
Zhang, Jiacheng, He, Gang, Jin, Xi, Alenezi, Bandar T, Naeem, Abdulghani A, Abdulsamad, Saud A and Ke, Youqiang ORCID: 0000-0001-5341-8644
(2023)
Molecular mechanisms on how FABP5 inhibitors promote apoptosis-induction sensitivity of prostate cancer cells.
Cell biology international, 47 (5).
pp. 929-942.
Naeem, Abdulghani A, Abdulsamad, Saudi A, Al-Bayati, Asmaa, Zhang, Jiacheng, Malki, Mohammed I, Ma, Hongwen and Ke, Youqiang ORCID: 0000-0001-5341-8644
(2022)
Prostate Cell Lines.
Journal of Oncology and Medicine.